Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,106 public trials 2,040 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Lenalidomide Therapy After Chemotherapy & Stem Cell Transplant in Treating Chemotherapy Resistan Non-Hodgkin Lymphoma

NCT01035463

Conditions
Anaplastic Large Cell Lymphoma, ALK-negative, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations
  • University of Kansas Hospital-Westwood Cancer Center Westwood, Kansas, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
  • Seidman Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
View Trial Details
Completed

A Study of Obinutuzumab, Rituximab, Polatuzumab Vedotin, and Venetoclax in Relapsed or Refractory Follicular Lymphoma (FL) or Diffuse Large B-Cell Lymphoma (DLBCL)

NCT02611323

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Memorial Healthcare System Pembroke, Florida, United States
  • Emory Univ Winship Cancer Inst Atlanta, Georgia, United States
View all 23 locations
View Trial Details
Completed

A Study of Durvalumab in Combination With Lenalidomide With and Without Dexamethasone in Adults With Newly Diagnosed Multiple Myeloma

NCT02685826

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 54 locations
View Trial Details

Related conditions